These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27820679)
21. A physiologically based pharmacokinetic model of organophosphate dermal absorption. van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965 [TBL] [Abstract][Full Text] [Related]
22. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Nielsen JB; Nielsen F; Sørensen JA Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442 [TBL] [Abstract][Full Text] [Related]
23. Dermal absorption of a dilute aqueous solution of malathion. Scharf JE; Johnson GT; Harbison SC; McCluskey JD; Harbison RD J Emerg Trauma Shock; 2008 Jul; 1(2):70-3. PubMed ID: 19561983 [TBL] [Abstract][Full Text] [Related]
24. Monitoring of pesticide applicators for potential dermal exposure to malathion and biomarkers in urine. Tuomainen A; Kangas JA; Meuling WJ; Glass RC Toxicol Lett; 2002 Aug; 134(1-3):125-32. PubMed ID: 12191870 [TBL] [Abstract][Full Text] [Related]
25. Significance of the dermal route of exposure to risk assessment. Mattie DR; Grabau JH; McDougal JN Risk Anal; 1994 Jun; 14(3):277-84. PubMed ID: 8029499 [TBL] [Abstract][Full Text] [Related]
26. The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution-A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling. Gaohua L; Zhang M; Sychterz C; Chang M; Schmidt BJ Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003416 [TBL] [Abstract][Full Text] [Related]
27. A real-time in-vivo method for studying the percutaneous absorption of volatile chemicals. Thrall KD; Poet TS; Corley RA; Tanojo H; Edwards JA; Weitz KK; Hui X; Maibach HI; Wester RC Int J Occup Environ Health; 2000; 6(2):96-103. PubMed ID: 10828137 [TBL] [Abstract][Full Text] [Related]
28. Correlation of fluorescent tracer measurements of dermal exposure and urinary metabolite excretion during occupational exposure to malathion. Fenske RA Am Ind Hyg Assoc J; 1988 Sep; 49(9):438-44. PubMed ID: 3177222 [TBL] [Abstract][Full Text] [Related]
29. Methods of assessing dermal absorption with emphasis on uptake from contaminated vegetation. Durkin PR; Rubin L; Withey J; Meylan W Toxicol Ind Health; 1995; 11(1):63-79. PubMed ID: 7652752 [TBL] [Abstract][Full Text] [Related]
30. Derivation of avian dermal LD50 values for dermal exposure models using in vitro percutaneous absorption of [ Maul JD; Blackstock C; Brain RA Sci Total Environ; 2018 Jul; 630():517-525. PubMed ID: 29486444 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the dermal bioavailability of aqueous xylene in F344 rats and human volunteers. Thrall K; Woodstock A J Toxicol Environ Health A; 2003 Jul; 66(13):1267-81. PubMed ID: 12851123 [TBL] [Abstract][Full Text] [Related]
32. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Corley RA; Gordon SM; Wallace LA Toxicol Sci; 2000 Jan; 53(1):13-23. PubMed ID: 10653516 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the dermal absorption of aqueous toluene in F344 rats using real-time breath analysis and physiologically based pharmacokinetic modeling. Thrall KD; Woodstock AD J Toxicol Environ Health A; 2002 Dec; 65(24):2087-100. PubMed ID: 12515588 [TBL] [Abstract][Full Text] [Related]
34. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans. Corley RA; Markham DA; Banks C; Delorme P; Masterman A; Houle JM Fundam Appl Toxicol; 1997 Oct; 39(2):120-30. PubMed ID: 9344624 [TBL] [Abstract][Full Text] [Related]
35. Modeling of human dermal absorption of octamethylcyclotetrasiloxane (D(4)) and decamethylcyclopentasiloxane (D(5)). Reddy MB; Looney RJ; Utell MJ; Plotzke KP; Andersen ME Toxicol Sci; 2007 Oct; 99(2):422-31. PubMed ID: 17630416 [TBL] [Abstract][Full Text] [Related]
36. Malathion disposition in dermally and orally treated rats and its impact on the blood serum acetylcholine esterase and protein profile. Abou Zeid MM; el-Barouty G; Abdel-Reheim E; Blancato J; Dary C; el-Sebae AH; Saleh MA J Environ Sci Health B; 1993 Aug; 28(4):413-30. PubMed ID: 8335887 [TBL] [Abstract][Full Text] [Related]
37. Predicting vehicle effects on the dermal absorption of halogenated methanes using physiologically based modeling. Jepson GW; McDougal JN Toxicol Sci; 1999 Apr; 48(2):180-8. PubMed ID: 10353309 [TBL] [Abstract][Full Text] [Related]
38. The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine. Bessems JGM; Paini A; Gajewska M; Worth A Toxicology; 2017 Dec; 392():119-129. PubMed ID: 28288858 [TBL] [Abstract][Full Text] [Related]
39. Dermal absorption of arsenic from soils as measured in the rhesus monkey. Lowney YW; Wester RC; Schoof RA; Cushing CA; Edwards M; Ruby MV Toxicol Sci; 2007 Dec; 100(2):381-92. PubMed ID: 17872898 [TBL] [Abstract][Full Text] [Related]
40. Absorption and excretion of organophosphorous insecticide biomarkers of malathion in the rat: implications for overestimation bias and exposure misclassification from environmental biomonitoring. Chen L; Zhao T; Pan C; Ross J; Ginevan M; Vega H; Krieger R Regul Toxicol Pharmacol; 2013 Apr; 65(3):287-93. PubMed ID: 23333519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]